For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.
Scope of the Report:
This report focuses on the Hirudin in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
- The Medicines Company
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
Market Segment by Countries, covering
- United States
Market Segment by Type, covers
- Natural Hirudin
- Recombinant Hirudin
Market Segment by Applications, can be divided into
- Thrombosis Disease
- Tumor Disease
There are 15 Chapters to deeply display the North America Hirudin market.
Chapter 1, to describe Hirudin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Hirudin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Hirudin, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Hirudin market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Hirudin Research Findings and Conclusion, Appendix, methodology and data source